Sch 434

08/01/1995 - "The results of the study demonstrate that SCH 434 QD is more effective than placebo or either of its components alone in the treatment of seasonal allergic rhinitis."
06/01/1989 - "We conclude that SCH 434 is a safe and effective treatment for symptoms of seasonal allergic rhinitis. "
08/01/1995 - "SCH 434 QD was consistently superior to placebo in controlling the symptoms of seasonal allergic rhinitis. "
01/01/1994 - "Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis."
06/01/1989 - "SCH 434: a new antihistamine/decongestant for seasonal allergic rhinitis."

06/01/1989 - "All treatments were safe and well tolerated, although insomnia and dry mouth were noted in a significant number of patients who received either SCH 434 or pseudoephedrine. "
08/01/1995 - "Insomnia and nervousness, adverse events commonly associated with pseudoephedrine, were noted in a significantly greater number of patients treated with SCH 434 QD or pseudoephedrine (p < or = 0.04) as compared with those treated with loratadine or placebo. "

01/01/1994 - "A smaller proportion of patients in the SCH 434 group reported side effects, especially dry mouth (7% vs 19%, P = 0.07), fatigue (6% vs 25%, P < 0.01), and sedation (7% vs 22%, P < 0.03). "